isomethyleugenol has been researched along with Carcinoma, Ductal, Breast in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Li, X; Liu, L; Sun, L; Xia, W; Yu, Y; Zhang, Y | 1 |
| Bonaldi, T; Minucci, S; Noberini, R; Pruneri, G; Uggetti, A | 1 |
| Chen, L; Chen, Y; Di, GH; Jin, W; Shao, ZM; Wu, J; Xu, SG; Yin, WJ | 1 |
| Liang, X; Liu, T; Liu, XS; Liu, Y; Ma, Y; Niu, M; Pang, D; Ren, Y; Shan, M; Song, Q; Sun, Q; Sun, S; Wei, W; Xia, B; Yang, L; Yang, Y; Zhang, G; Zhang, X; Zhang, Y | 1 |
| Chow, LW; Hu, XC; Loo, WT | 1 |
| Baylin, SB; Bonilla, F; Bussaglia, E; Dominguez, G; Esteller, M; Gabrielson, E; Harkes, IC; Herman, JG; Lerma, E; Matias-Guiu, X; Prat, J; Repasky, EA; Schutte, M; Silva, JM | 1 |
6 other study(ies) available for isomethyleugenol and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients.
Topics: Acid Anhydride Hydrolases; BRCA1 Protein; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; DNA Methylation; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasm Proteins; Promoter Regions, Genetic | 2015 |
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.
Topics: Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Female; Histones; Humans; Leukemia, Promyelocytic, Acute; Methylation; Mice; Protein Processing, Post-Translational; Proteomics; Tandem Mass Spectrometry; Tissue Fixation | 2016 |
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Topics: Acetylation; Binding Sites; BRCA1 Protein; Breast Neoplasms; Carcinoma, Ductal, Breast; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Chromatin Assembly and Disassembly; Chromatin Immunoprecipitation; CREB-Binding Protein; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; E1A-Associated p300 Protein; Epigenesis, Genetic; Estradiol; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histocompatibility Antigens; Histone Deacetylase 1; Histone-Lysine N-Methyltransferase; Histones; Humans; Hydrogen Peroxide; Immunohistochemistry; Methylation; MyoD Protein; Oxidants; Oxidative Stress; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription, Genetic; Transfection; Ubiquitin-Protein Ligases | 2010 |
Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.
Topics: Adult; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; DNA Copy Number Variations; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Methylation; Middle Aged; Mutation; Neoplasm Invasiveness; Nuclear Proteins; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors | 2013 |
E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman.
Topics: Actins; Adult; Aged; Blotting, Western; Breast Neoplasms; Cadherins; Carcinoma, Ductal, Breast; China; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Middle Aged; Neoplasm Proteins; Prognosis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Loss of Heterozygosity; Methylation; Ovarian Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |